Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Bruno Ledergerber

Biographic Data

ID7734242
NAMEBruno Ledergerber
GIVEN NAMESBruno
FAMILY NAMELedergerber
SIGNATURELEDERGERBER B
AFFILIATIONSUniversity of Zurich
ORCID0000-0002-6881-4401
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2002
LATEST PUBLICATION YEAR2021
H-INDEX0
  • A Lower CD4 Count Predicts Most Causes of Death except Cardiovascular Deaths. The Austrian HIV Cohort Study

    Open Access•Gisela Leierer, Armin Rieger et al.•ARTICLE•International Journal of…•2021

    (1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as well as specific causes of death over time among HIV-positive individuals in the combination antiretroviral therapy (cART) era. (2) Methods: We analyzed all-cause as well as cause-specific mortality among the Austrian HIV Cohort Study between 1997 and 2014. Observation time was divided into five periods: Period 1: 1997-2000; period 2: 2001-2004; peri…

  • Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study

    Open Access•The Swiss HIV Cohort Study, Olivia Keiser et al.•ARTICLE•AIDS and Behavior•2011

  • Costs of treatment of Swiss patients with HIV on antiretroviral therapy in hospital-based and general practice-based care

    A Lowy, J Page et al.•ARTICLE•AIDS Care•2005

    Some ambulant people with HIV are cared for primarily by their general practitioner and some in an outpatient clinic. Costs and patterns of care in these settings were studied in 65 such patients based in Zürich, from a limited societal perspective (excluding patient costs) based on medical resource use. Antiretroviral therapy (ART), other medications and patient variables were collected prospectively, and non-medication resources (professional t…

  • Decline in the Aids and death rates in the EuroSida study

    Open Access•Amanda Mocroft, Bruno Ledergerber et al.•ARTICLE•The Lancet•2003

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy

    Open Access•Matthias Egger, Margaret May et al.•ARTICLE•The Lancet•2002

No prominent works on this page.

  • Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy

    Open Access•Matthias Egger, Margaret May et al.•ARTICLE•The Lancet•2002

  • Decline in the Aids and death rates in the EuroSida study

    Open Access•Amanda Mocroft, Bruno Ledergerber et al.•ARTICLE•The Lancet•2003

  • Costs of treatment of Swiss patients with HIV on antiretroviral therapy in hospital-based and general practice-based care

    A Lowy, J Page et al.•ARTICLE•AIDS Care•2005

    Some ambulant people with HIV are cared for primarily by their general practitioner and some in an outpatient clinic. Costs and patterns of care in these settings were studied in 65 such patients based in Zürich, from a limited societal perspective (excluding patient costs) based on medical resource use. Antiretroviral therapy (ART), other medications and patient variables were collected prospectively, and non-medication resources (professional t…

  • Outcomes of Antiretroviral Therapy in the Swiss HIV Cohort Study

    Open Access•The Swiss HIV Cohort Study, Olivia Keiser et al.•ARTICLE•AIDS and Behavior•2011

  • A Lower CD4 Count Predicts Most Causes of Death except Cardiovascular Deaths. The Austrian HIV Cohort Study

    Open Access•Gisela Leierer, Armin Rieger et al.•ARTICLE•International Journal of…•2021

    (1) Objective: To investigate changes in mortality rates and predictors of all-cause mortality as well as specific causes of death over time among HIV-positive individuals in the combination antiretroviral therapy (cART) era. (2) Methods: We analyzed all-cause as well as cause-specific mortality among the Austrian HIV Cohort Study between 1997 and 2014. Observation time was divided into five periods: Period 1: 1997-2000; period 2: 2001-2004; peri…

Antiretroviral therapy (5 works) · HIV/AIDS Research and Interventions (5 works) · Medicine (5 works) · Viral load (5 works) · Cohort (4 works) · Cohort study (4 works) · Confidence interval (3 works) · HIV Research and Treatment (3 works) · HIV/AIDS drug development and treatment (3 works) · Internal Medicine (3 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae